Last updated: October 18, 2020
Sponsor: Tel-Aviv Sourasky Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Arrhythmia
Chest Pain
Atrial Fibrillation
Treatment
N/AClinical Study ID
NCT04600245
TASMC-05- EC- 0457-20-TLV
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female >18 years old.
Subjects must provide written informed consent to participate in the study.
Subject is willing to comply with the protocol requirements and return to thetreatment center for all required clinical evaluations.
Exclusion
Exclusion Criteria:
Pregnant women.
Patients with iodine contrast media allergy
Patients with renal failure (GFR <60ml/min)
Study Design
Total Participants: 60
Study Start date:
October 01, 2020
Estimated Completion Date:
October 01, 2023
Study Description
Connect with a study center
Tel Aviv Medical Center
Tel Aviv,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.